Tau Phosphorylation, Aggregation, and Cell Toxicity
Open Access
- 3 January 2006
- journal article
- review article
- Published by Wiley in BioMed Research International
- Vol. 2006 (1) , 74539
- https://doi.org/10.1155/jbb/2006/74539
Abstract
Protein aggregation takes place in many neurodegenerative disorders. However, there is a controversy about the possible toxicity of these protein aggregates. In this review, this controversy is discussed, focussing on the tau aggregation that takes place in those disorders known as tauopathies.Keywords
This publication has 57 references indexed in Scilit:
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Protein aggregation and neurodegenerative diseaseNature Medicine, 2004
- Zeta 14-3-3 protein favours the formation of human tau fibrillar polymersNeuroscience Letters, 2004
- Tau Polymerization: Role of the Amino TerminusBiochemistry, 2003
- Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's diseaseNeuroscience Letters, 1995
- The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's diseaseFEBS Letters, 1992
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Proteolysis of tau by calpainBiochemical and Biophysical Research Communications, 1989
- Self assembly of microtubule associated protein tau into filaments resembling those found in alzheimer diseaseBiochemical and Biophysical Research Communications, 1986